Wellington Partners raises EUR 210 million life science fund31. July 2019|In Wellington Partners|By eazee-designstudioWellington Partners today announced the final close of its fifth-generation fund Wellington Partners Life Science Fund V (WPLS-V). The fund closed at EUR 210 million, making it the largest life science dedicated fund raised by Wellington Partners to date. WPLS-V will build a portfolio of approximately 15-20 companies, ranging in focus from novel biotechnology platforms, new therapeutics and medical devices, including selected investments in diagnostics and digital medicine. All of the fund’s investments will target substantial improvements to current medical practice for the benefit of patients, practitioners, and payors alike. PrevNext
